PROP Q1 2026 Earnings Massive EPS Miss as Stock Rises 905 Amid Lack of Revenue Disclosure MGEE Q1 2026 Earnings EPS Surpasses Estimates on Strong Utility Performance Bicara Therapeutics BCAX Q1 2026 Earnings ClinicalStage Biotech Reports WiderthanExpected Loss Shares Rise EXAS Q4 2025 Earnings Significant EPS Miss Amidst Challenging Quarter BiomX Inc PHGE Q4 2025 Earnings EPS Misses by Wide Margin No Revenue Stock Declines GLUE Q1 2026 Earnings WiderThanExpected Loss as PreClinical Biotech Advances Pipeline